Company-wide revenue
Reported revenue in 2021 ¥189.28B Reported revenue in 2025 ¥194.9B
- growth amount
- +¥5.61B
- growth annualized
- +0.7%
- growth total
- +3.0%
Japanese company profile · 7915
Nissha Co., Ltd.
In its FY2025 public filing, Nissha Co., Ltd. reports Industrial Materials, Devices, Medical Technology. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: ＮＩＳＳＨＡ株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Nissha Co., Ltd.'s largest reported business by revenue in FY2025 was Industrial Materials.
The business with the highest reported segment profit in FY2025 was Industrial Materials.
FY2025 · fiscal year ended December 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Revenue from external customers | Revenue share | Segment profit (loss) |
|---|---|---|---|
| Industrial Materials | ¥76.31B ↗ | 39.2% | ¥3.74B ↗ |
| Devices | ¥58.45B ↗ | 30.0% | ¥2.13B ↗ |
| Medical Technology | ¥47.13B ↗ | 24.2% | ¥2.04B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended December 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Industrial Materials
- 産業資材
- Devices
- ディバイス
- Medical Technology
- メディカルテクノロジー
- Revenue from external customers
- 外部顧客売上
- Segment profit (loss)
- セグメント利益（損失）
Original Japanese label
- Industrial Materials
- 産業資材
- Devices
- ディバイス
- Medical Technology
- メディカルテクノロジー
- Revenue from external customers
- 外部顧客売上
- Segment profit (loss)
- セグメント利益（損失）
Reported Revenue from external customers by business over time
Reported Revenue from external customers by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Industrial Materials | ¥60.54B | ¥73.56B | ¥68.76B | ¥74.09B | ¥76.31B |
| Devices | ¥96.97B | ¥79.95B | ¥54.86B | ¥67.54B | ¥58.45B |
| Medical Technology | ¥24.18B | ¥32.46B | ¥36.01B | ¥45.62B | ¥47.13B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Medical Technology
Reported revenue in 2021 ¥24.18B Reported revenue in 2025 ¥47.13B
- growth amount
- +¥22.95B
- growth annualized
- +18.2%
- growth total
- +94.9%
View original filing
Medical Technology
Reported profit margin in 2022 +1.5%
Reported profit margin in 2025 +4.3%
- growth margin points
- +2.8
View original filing
Industrial Materials
Reported profit margin in 2022 +4.6%
Reported profit margin in 2025 +4.9%
- growth margin points
- +0.3
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended December 2025
The source document may be in Japanese.
Filing ID: S100XS06
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.